Nitric oxide signalling in cardiovascular health and disease

C Farah, LYM Michel, JL Balligand - Nature Reviews Cardiology, 2018 - nature.com
Nitric oxide (NO) signalling has pleiotropic roles in biology and a crucial function in
cardiovascular homeostasis. Tremendous knowledge has been accumulated on the …

Therapeutic targets for cardiac fibrosis: from old school to next-gen

JG Travers, CA Tharp, M Rubino… - The Journal of clinical …, 2022 - Am Soc Clin Investig
Cardiovascular diseases remain the leading cause of death worldwide, with pathological
fibrotic remodeling mediated by activated cardiac myofibroblasts representing a unifying …

New insights in cardiac β-adrenergic signaling during heart failure and aging

C Lucia, A Eguchi, WJ Koch - Frontiers in pharmacology, 2018 - frontiersin.org
Heart failure (HF) has become increasingly common within the elderly population,
decreasing their survival and overall quality of life. In fact, despite the improvements in …

The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications

F Triposkiadis, G Karayannis, G Giamouzis… - Journal of the American …, 2009 - jacc.org
Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers
countermeasures aimed to restore cardiac output. These responses are compensatory at …

Treatments targeting inotropy: a position paper of the Committees on Translational Research and Acute Heart Failure of the Heart Failure Association of the European …

C Maack, T Eschenhagen, N Hamdani… - European heart …, 2019 - academic.oup.com
Acute heart failure (HF) and in particular, cardiogenic shock are associated with high
morbidity and mortality. A therapeutic dilemma is that the use of positive inotropic agents …

Nitric oxide and cardiac function: ten years after, and continuing

PB Massion, O Feron, C Dessy, JL Balligand - Circulation research, 2003 - Am Heart Assoc
Nitric oxide (NO) is produced from virtually all cell types composing the myocardium and
regulates cardiac function through both vascular-dependent and-independent effects. The …

Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask)

G Schena, MJ Caplan - Cells, 2019 - mdpi.com
The beta-3 adrenergic receptor (β3-AR) is by far the least studied isotype of the beta-
adrenergic sub-family. Despite its study being long hampered by the lack of suitable animal …

Catecholamine-dependent β-adrenergic signaling in a pluripotent stem cell model of takotsubo cardiomyopathy

T Borchert, D Hübscher, CI Guessoum… - Journal of the American …, 2017 - jacc.org
Background: Takotsubo syndrome (TTS) is characterized by an acute left ventricular
dysfunction and is associated with life-threating complications in the acute phase. The …

Positive inotropic and lusitropic effects of HNO/NO in failing hearts: Independence from β-adrenergic signaling

N Paolocci, T Katori, HC Champion… - Proceedings of the …, 2003 - National Acad Sciences
Nitroxyl anion (HNO/NO−), the one-electron reduced form of nitric oxide (NO), induces
positive cardiac inotropy and selective venodilation in the normal in vivo circulation. Here we …

Adrenergic receptors in individual ventricular myocytes: the beta-1 and alpha-1B are in all cells, the alpha-1A is in a subpopulation, and the beta-2 and beta-3 are …

BE Myagmar, JM Flynn, PM Cowley… - Circulation …, 2017 - Am Heart Assoc
Rationale: It is unknown whether every ventricular myocyte expresses all 5 of the cardiac
adrenergic receptors (ARs), β1, β2, β3, α1A, and α1B. The β1 and β2 are thought to be the …